Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2005
06/08/2005CN1625596A Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
06/08/2005CN1625563A Novel fungal lipase
06/08/2005CN1625385A Lipase inhibiting composition
06/08/2005CN1624138A Coding gene of peptidyl proacyl cis-trans isomerase
06/08/2005CN1624137A Coding gene of cellulose of glycosyl hydrolase family 5 and its application
06/08/2005CN1624136A Genes coding for flavone synthases
06/08/2005CN1624135A DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/08/2005CN1624124A Amylase variants
06/08/2005CN1624123A Method for the recombinant production and purification of protein kinases
06/08/2005CN1624122A Recombinantly expressed carboxypeptidase b and purification thereof
06/08/2005CN1624121A Alpha-acetyl lactate dehydrogenase dry powder and its preparation process
06/08/2005CN1624120A Salt Du's algal (6-4) and its coding sequence
06/08/2005CN1624119A Enolase salt Du's algal enolase and its coding sequence
06/08/2005CN1624118A Process for purification preparing DNA optical repairase
06/08/2005CN1624114A Transgenic plant resistant to mycotoxins and methods
06/08/2005CN1205339C Method for producing L-glutaminc acid
06/08/2005CN1205337C Method for culturing microorganisms having methanol metabolic pathway
06/07/2005US6903247 Constitutive α-Tubulin promoter from coffee plants and uses thereof
06/07/2005US6903246 Comprises nucleotide sequences coding dehydroascorbate reductase (DHAR) for use in reducing concentration of ascorbic acid in plants; drought tolerance
06/07/2005US6903245 Polynucleotide molecule from haematococcus pluvialis encoding a polypeptide having a ⊕-c-4-oxygenase activity for biotechnological production of (3s,3's) astaxanthin and its specific expression in chromoplasts of higher plants
06/07/2005US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods
06/07/2005US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer
06/07/2005US6903193 Proteins containing specific amino acid squences obtained from a Fusarium strain
06/07/2005US6903190 Nematode ATP synthase subunit E-like sequences
06/07/2005US6903189 Polypeptide for use in the treatment of cancer, arthritis, psoriasis and diabetes
06/07/2005US6903069 Factor VII glycoforms
06/07/2005US6902924 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
06/07/2005US6902923 For pharmacogenomic applications; cosmetics; nutriceuticals; fusion proteins
06/07/2005US6902922 Subtilisin variants
06/07/2005US6902921 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules
06/07/2005US6902920 Method for producing an active heterodimeric AMV-RT in prokaryotic cells
06/07/2005US6902919 Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; may be used to identify antibodies and other agents that inhibit DSP-12 and/or DSP-13 activity and to modulate cell proliferation
06/07/2005US6902918 Oxygenase enzymes and screening method
06/07/2005US6902915 Comprise heat resistant proteolytic enzyme for conversion of N-acyl-DL-amino acid such as N-acetyl-DL-methionine into corespondinng D-methionine
06/07/2005US6902913 Recombinant narbonolide polyketide synthase
06/07/2005CA2270872C Nematode-inducible regulatory dna sequences
06/07/2005CA2270593C Subtilase variants and compositions
06/04/2005CA2486900A1 A method for obtaining circular mutated and/or chimaeric polynucleotides
06/02/2005WO2005050222A1 Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
06/02/2005WO2005050216A1 Identification of toxin-binding protein involved in resistance to cry1 toxins, and related screening methods
06/02/2005WO2005049853A2 Compositions and methods for screening pro-apoptotic compounds
06/02/2005WO2005049847A1 Fusion proteins and methods of cleavage of such proteins
06/02/2005WO2005049842A2 Improved targeted dna insertion in plants
06/02/2005WO2005049831A1 Method
06/02/2005WO2005049823A1 Secretory protein production system
06/02/2005WO2005049822A1 Method of growing myocardial cells
06/02/2005WO2005049818A2 Genes encoding human deubiquitinating enzymes
06/02/2005WO2005049816A2 Oxidoreductase from metschnikowia zobellii
06/02/2005WO2005049805A2 Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast
06/02/2005WO2005049643A1 Novel carotenoid hydroxylase gene, process for producing hydroxylated carotenoid, and novel geranylgeranyl pyrophosphate synthase gene
06/02/2005WO2005049630A2 Antisense modulation of kinesin-like 1 expression
06/02/2005WO2005048692A2 Tomatoes having reduced deoxyhypusine synthase activity caused by non-transgenic alterations in a deoxyhypusine synthase gene
06/02/2005WO2005035749A3 Animal product free media and processes for obtaining a botulinum toxin
06/02/2005WO2005030241A3 Treating inflammation using a biological agent that causes cells to release cytokine receptors
06/02/2005WO2005029039A3 Non-radioactive inositol phosphate assay for phospholipase c-coupled drug target screening
06/02/2005WO2005026368A3 Dihydroflavonol-4-reductase
06/02/2005WO2005023856A3 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
06/02/2005WO2005017115A3 Cord blood-derived hematopoietic progenitor cells
06/02/2005WO2005007845A3 Transgenic cells
06/02/2005WO2005001041A3 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
06/02/2005WO2004101741A3 Transgenic plants with increased glycine-betaine
06/02/2005WO2004094601A3 Methods of treating pin1 associated disorders by covalent modification of active site residues
06/02/2005WO2004093797A3 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
06/02/2005WO2004083393A3 Enhanced protein thermostability and temperature resistance
06/02/2005WO2004076625A3 Method of identifying plant cells transformed with a gene
06/02/2005WO2004021981A3 METHODS FOR THE PREPARATION OF β-AMINO ACIDS
06/02/2005WO2004013347A8 Methods of identifying compounds that modulate protein activity
06/02/2005WO2004007691A3 Herbicide-resistant plants, and polynucleotides and methods for providing same
06/02/2005WO2003089610A8 Fatty alcohol oxidase genes and proteins from candida troplicalis and methods relating thereto
06/02/2005WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
06/02/2005WO2003068932A8 Method for crystallizing human gsk3 and novel crystal structure thereof
06/02/2005WO2003013226A3 Non-transgenic herbicide resistant plants
06/02/2005US20050120418 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes
06/02/2005US20050120413 Expression vector comprising polynucleotide encoding aberrant adp-glucose pyrophosphorylase for use as tool in generating plants with increase yields in high heat environments
06/02/2005US20050120407 Geranylgeranyl pyrophosphate synthases
06/02/2005US20050120406 Nucleic acid sequences to proteins involved in isoprenoid synthesis
06/02/2005US20050120405 Expression vector comprising nucleotide sequences coding threonine synthase for use in transformation and enhancing biosynthesis of lysine, leucine, threonine cysteine and isoleucine from aspartate in plants
06/02/2005US20050120400 Genetically engineered, galactosyltransferase deficient, pigs for use as source of organs, tissues and cells for xenotransplantation
06/02/2005US20050120396 Human MEKK1 protein and nucleic acid molecules and uses therefor
06/02/2005US20050120395 Using vector comprising homing endonuclease gene (HEG) as tool in gnerating transgenic cells; heterologous gene transfer; improving exogenous gene expression
06/02/2005US20050119464 Protein
06/02/2005US20050119460 Gene associated with Leishmania parasite virulence
06/02/2005US20050119457 Human proteins
06/02/2005US20050119213 Vascular therapeutics
06/02/2005US20050119209 Compositions and methods for the treatment and diagnosis of immune disorders
06/02/2005US20050119205 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions
06/02/2005US20050118697 Method of preparing a dough or baked product made from a dough, with addition of lipolytic enzymes
06/02/2005US20050118696 Methods and means for modulating PGE synthase activity
06/02/2005US20050118695 Alpha-amylase mutants
06/02/2005US20050118689 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
06/02/2005US20050118687 Methods of synthesizing polynucleotide via reverse translation from protein and oligonucleotide used in this method
06/02/2005US20050118679 Novel metalloproteinases
06/02/2005US20050118668 Non-radioactive label fluorophore covalently bonded to a modified tyrosine residue
06/02/2005US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents
06/02/2005US20050118632 Polynucleotides and polypeptides encoding a novel metalloprotease, Protease-40b
06/02/2005US20050118610 Nucleotide sequences coding hydrolase for generating protein hydrolysates useful as flavour improving agents; food processing
06/02/2005US20050118608 shares characteristics with members of the tyrosine kinase family; given sequences; drug screening for modulators of the kinase
06/02/2005US20050118604 Modulators of angiogenesis and tumorigenesis
06/02/2005US20050118594 Enzymes
06/02/2005US20050118590 Novel gene cluster of pederin biosynthesis genes